Mounjaro Maintenance Providers UK
Listed fees and provider policies can change. Always confirm current eligibility, availability and terms with the provider before proceeding.
Already using Mounjaro and considering a different provider? This guide explains how continuation requests usually work, what to compare before switching, and how to reduce the risk of a treatment gap.
Some UK providers may review patients who are already using Mounjaro and want to continue treatment after starting elsewhere. That can be useful if you are comparing displayed prices, looking for a better service fit, or dealing with stock or delivery problems.
What matters most is that continuation is never automatic. Even where a provider considers maintenance patients, it should still carry out its own medical and prescribing review before deciding whether treatment can continue through that route.
What continuation providers are
For this page, continuation providers are UK providers that may consider patients who have already started Mounjaro elsewhere and want to continue through a new provider route.
Users usually compare continuation routes for four main reasons:
- Displayed price differences between one provider and another
- Stock or fulfilment reliability if the current provider becomes difficult to use
- Service structure such as support level, review style, or delivery options
- Practical fit where another provider better matches budget, communication style, or treatment stage
What providers usually review before accepting continuation patients
Although providers may consider continuation requests, a new provider will usually still assess whether ongoing treatment is appropriate under its own standards.
Typical continuation-review factors
- Your current or recent Mounjaro treatment history
- Your current dose and how treatment has progressed so far
- Relevant side effects, tolerability issues, or safety concerns
- Your broader medical history and current medication
- Whether you still fit the provider’s own eligibility and prescribing criteria
- Completion of a fresh questionnaire, consultation, or prescribing review
Key point: being accepted by one provider does not mean another provider will make the same decision. Each provider remains responsible for its own clinical judgement.
For broader background on eligibility and medical suitability, read the eligibility guide.
Why people switch continuation providers
Pricing differences
Displayed prices can differ across providers for the same or similar stage of treatment, so switching may reduce monthly cost in some cases.
Supply continuity
If stock issues or fulfilment delays arise, another provider route may offer a more stable continuation option.
Service fit
Users sometimes want a different review style, better support, clearer communication, or a delivery model that suits them better.
Illustrative example of how costs can diverge over time
The table below is only a simple illustration. Real cost depends on dose, service structure, delivery charges, and the provider being compared.
Illustrative 6-month comparison
| Month | Higher-cost provider | Alternative provider | Difference |
|---|---|---|---|
| Month 1 | £299 | £189 | £110 |
| Month 2 | £319 | £209 | £110 |
| Month 3 | £339 | £229 | £110 |
| Month 4 | £359 | £249 | £110 |
| Month 5 | £379 | £269 | £110 |
| Month 6 | £399 | £289 | £110 |
| 6-month total | £2,094 | £1,434 | £660 |
Other common reasons to switch
- To reduce the chance of a treatment gap during stock issues
- To move to a provider with more convenient delivery or contact routes
- To access a different support model such as monitoring or coaching
- To find a better overall fit for budget, communication, or service expectations
Compare UK continuation providers
Use the comparison tool below to review providers that may consider continuation patients. Compare displayed pricing, service notes, and provider fit for your current stage of treatment.
Useful comparison approach: if you expect a dose change soon, compare both your current dose and the next likely dose instead of deciding on one month’s displayed price alone.
💡 Why are maintenance prices often cheaper?
Maintenance providers supply Mounjaro only to patients with an approved prescription. They require less clinician time for assessments, making them more affordable. However, you'll typically need proof of previous treatment.
⚠️ Not suitable for first-time users | ✅ Perfect for ongoing treatment
| # | Pharmacy | Status | Price (5mg) | Notes |
|---|---|---|---|---|
| 1 |
Lotus Weight Loss
⭐ 4.4 Trustpilot
|
✨ New Patients ✓ Maintenance 🔄 Restart 💬 Support |
£143.00
per pen
|
— |
| 2 |
The Family Chemist
⭐ 4.8 Trustpilot
|
✨ New Patients ✓ Maintenance |
£144.99
per pen
|
— |
| 3 |
PillSorted
⭐ 4.7 Trustpilot
|
✨ New Patients ✓ Maintenance 🔄 Restart |
£145.99
per pen
|
— |
| 4 |
Get A Drip
⭐ 3.0 Trustpilot
|
✨ New Patients ✓ Maintenance 🔄 Restart |
£149.00
per pen
|
— |
| 5 |
WePrescribe
⭐ 4.9 Trustpilot
|
✨ New Patients ✓ Maintenance |
£149.99
per pen
|
— |
| 6 |
OnlineMeds
⭐ 4.7 Trustpilot
|
✨ New Patients ✓ Maintenance |
£152.49
per pen
|
— |
| 7 |
Tribelle
⭐ 4.7 Trustpilot
|
✨ New Patients ✓ Maintenance 🔄 Restart |
£153.99
per pen
|
— |
| 8 |
Swift Doctor
⭐ 4.9 Trustpilot
|
✨ New Patients ✓ Maintenance 🔄 Restart |
£159.00
per pen
|
— |
| 9 |
Pharmulous
⭐ 4.8 Trustpilot
|
✨ New Patients ✓ Maintenance |
£159.98
per pen
|
— |
| 10 |
Get Weightloss
⭐ 4.2 Trustpilot
|
✨ New Patients ✓ Maintenance |
£160.00
per pen
|
— |
| 11 |
Farmeci
⭐ 4.6 Trustpilot
|
✨ New Patients ✓ Maintenance 🔄 Restart |
£161.10
per pen
|
— |
| 12 |
My London Pharmacy
⭐ 4.6 Trustpilot
|
✨ New Patients ✓ Maintenance 💬 Support |
£161.10
per pen
|
— |
| 13 |
Cuva Health
⭐ 4.8 Trustpilot
|
✨ New Patients ✓ Maintenance |
£163.98
per pen
|
— |
| 14 |
Oushk
⭐ 4.7 Trustpilot
|
✨ New Patients ✓ Maintenance |
£163.99
per pen
|
— |
| 15 |
Dr Weightmans
⭐ 4.7 Trustpilot
|
✨ New Patients ✓ Maintenance |
£164.99
per pen
|
— |
Classifications last verified: 2026-01-01 | Based on Monj-verified lists
How switching usually works
Switching is often straightforward, but good timing matters because the new provider usually needs to complete its review before continuing supply.
Research and compare
- Review price, dose fit, delivery terms, and provider features.
- Check whether continuation patients are still being considered.
- Look at the wider service model, not just the headline price.
Gather your treatment details
- Note your current dose and treatment timeline.
- Keep relevant side-effect history and current medication details ready.
- Have any information the new provider may request available in advance.
Complete the new assessment
- Fill in the provider’s new questionnaire honestly and fully.
- Make clear that you are already on treatment and seeking continuation review.
- Wait for the provider’s own prescribing decision.
Order if approved
- Only place the order once approval is confirmed.
- Plan timing carefully so your current supply does not run out first.
- Check delivery expectations before relying on the new route.
Estimate a possible cost difference
Cost difference calculator
This calculator is only an illustration. Actual pricing, fees, and treatment plans can change.
Illustrative switching examples
These examples show the kinds of reasons users may switch. They are examples only, not promises of what any individual user will experience.
Cost-focused switch
- Original route: higher monthly cost on a continuation dose
- Reason for switching: price difference
- Main outcome: lower ongoing cost through a different provider route
“The main reason to move was cost. The comparison made it easier to see where the displayed price gap was meaningful over time.”
Supply-focused switch
- Original route: repeated stock or fulfilment delays
- Reason for switching: avoid interruption
- Main outcome: continuation through a provider with more reliable availability at the time
“The key issue was continuity rather than headline price. Switching reduced the risk of a treatment gap.”
Support-focused switch
- Original route: minimal service wrapper
- Reason for switching: broader support and clearer follow-up
- Main outcome: move to a provider model that better matched longer-term treatment needs
“The deciding factor was not only cost, but whether the provider offered the kind of support that made treatment easier to maintain.”
Frequently asked questions
Can I switch providers while already on Mounjaro?
Often yes, but the new provider should still make its own decision after carrying out a fresh review.
Will I need a new medical assessment?
Yes. Providers usually complete a new prescribing assessment even if treatment started elsewhere.
How long can switching take?
Timing varies by provider. Users should allow time for assessment, approval, and delivery rather than assuming immediate continuity.
Can I move back to my original provider later?
That depends on the provider’s own policies and whether it requires a fresh assessment again.
Do continuation providers always cost less?
No. Some may be cheaper, some similar, and some more expensive depending on the service model, dose, and overall package.
What if the new provider declines the continuation request?
That can happen because providers apply their own prescribing criteria. Another provider may review the case differently, but acceptance is never guaranteed.
Will switching affect treatment progress?
The key issue is avoiding unnecessary gaps and making sure the new provider agrees with the continuation pathway. Timing and clear communication matter.
Can public offers or discount codes still apply when switching?
Sometimes, but terms vary. Always check whether any displayed offer applies to continuation patients and not only to specific first-order conditions.
What happens to treatment records?
That depends on what is shared, what is requested, and how each provider handles records. Users can ask providers directly about record access and transfer processes.
Are providers on this page automatically suitable for me?
No. This page is a comparison aid, not a recommendation or suitability decision. Prescribing remains individual and provider-led.
Why this page can help
Continuation focus
Built for users who are already on treatment and want to compare continuation-friendly routes.
UK provider context
Framed around UK-regulated routes rather than informal or unclear sellers.
Comparison utility
Brings switching context and provider comparison together in one place.
Independent framing
Supports informed comparison without promising approval, prescribing, or outcomes.
Related resources
Restart providers
Looking for providers that may review treatment after a break.
View restart providers →Support providers
Compare routes that include broader coaching, follow-up, or support features.
Compare support providers →Full provider comparison
Review the wider UK provider comparison, not only continuation routes.
View full comparison →Useful next guides
These guides are often helpful when planning a switch or reviewing continuation options.
Ready to compare providers?
Review the wider UK provider comparison to compare displayed pricing, service structure, and provider fit for your current stage of treatment.
Compare UK providers →Medical disclaimer: This page is for information and comparison only and does not provide medical advice. Mounjaro is a prescription-only treatment. Any prescribing decision should be made by an appropriate healthcare professional after reviewing the individual case.
Pricing and provider status: Displayed prices, public offers, and continuation acceptance can change. Users should always verify current terms directly with the provider before relying on a listed route.
Continuation context: A provider being listed on this page does not guarantee acceptance for continuation prescribing. Each provider remains responsible for its own independent assessment and prescribing decision.
Comparison routes
Choose the next comparison step
Use these routes to compare listed provider information alongside dose context, eligibility guidance, safety checks and ongoing support. Confirm current fees, stock, suitability and prescribing requirements directly with providers.